Published in Lancet on January 03, 1987
Cryptosporidiosis. Clin Microbiol Rev (1991) 4.73
An outbreak of waterborne cryptosporidiosis caused by post-treatment contamination. Epidemiol Infect (1989) 3.06
Epidemiological aspects of human cryptosporidiosis. Epidemiol Infect (1990) 2.60
Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J Clin Microbiol (1999) 2.36
An outbreak of waterborne cryptosporidiosis in Swindon and Oxfordshire. Epidemiol Infect (1991) 2.21
ACP Broadsheet 128: June 1991. Laboratory methods for diagnosing cryptosporidiosis. J Clin Pathol (1991) 2.06
Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J Clin Microbiol (1989) 2.06
Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. Public Health Laboratory Service Study Group. BMJ (1990) 1.67
Detection of Cryptosporidium parvum oocysts in bovine feces by monoclonal antibody capture enzyme-linked immunosorbent assay. J Clin Microbiol (1990) 1.25
Nested polymerase chain reaction for amplification of the Cryptosporidium oocyst wall protein gene. Emerg Infect Dis (2001) 1.15
Cryptosporidiosis reservoir in wild brown rats (Rattus norvegicus) in the UK. Epidemiol Infect (1995) 1.02
Evaluation of an enzyme immunoassay kit for detecting cryptosporidium in faeces and environmental samples. J Clin Pathol (1992) 1.00
Caring for pets of immunocompromised persons. Can Vet J (1995) 0.95
Comparison of techniques for detecting antigens of Giardia lamblia and Cryptosporidium parvum in faeces. J Clin Pathol (1993) 0.88
Characterization and immunoprotective properties of a monoclonal antibody against the major oocyst wall protein of Eimeria tenella. Infect Immun (1996) 0.84
Laboratory examination for Cryptosporidium spp in Scotland. J Clin Pathol (1992) 0.75
PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol Lett (1997) 5.09
False positive reactions in the indirect fluorescent antibody test for Legionnaires' disease eliminated by use of formolised yolk-sac antigen. Ann Intern Med (1979) 3.59
Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis (2007) 3.50
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38
Laboratory diagnosis of cryptosporidiosis. J Clin Pathol (1985) 2.90
Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis (2002) 2.84
Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev (1996) 2.73
Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp. nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov. Int J Syst Bacteriol (1995) 2.68
Cryptosporidium species a "new" human pathogen. J Clin Pathol (1985) 2.63
A multi-centre study on the phage typing of Listeria monocytogenes. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 2.63
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43
Diagnosis of Legionella pneumophila infections by means of formolised yolk sac antigens. J Clin Pathol (1982) 2.37
Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) (2006) 2.36
Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA. J Med Microbiol (2001) 2.35
Static magnetic fields for treatment of fibromyalgia: a randomized controlled trial. J Altern Complement Med (2001) 2.34
Audit of pain after nasal surgery. Ann R Coll Surg Engl (1996) 2.10
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93
A method for typing strains of Legionella pneumophila serogroup 1 by analysis of restriction fragment length polymorphisms. J Med Microbiol (1990) 1.93
Aspects of the epidemiology of human Listeria monocytogenes infections in Britain 1967-1984; the use of serotyping and phage typing. J Med Microbiol (1986) 1.93
A rapid microagglutination test for the diagnosis of Legionella pneumophila (serogroup 1) infection. J Clin Pathol (1982) 1.90
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83
Legionnaires' disease: further evidence to implicate water storage and distribution systems as sources. Br Med J (Clin Res Ed) (1981) 1.77
Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-5. Epidemiol Infect (1998) 1.74
Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis (2001) 1.71
Gentamicin as a bactericidal agent in virological tissue cultures. J Clin Pathol (1967) 1.71
The evaluation of a phage-typing system for Listeria monocytogenes for use in epidemiological studies. J Med Microbiol (1986) 1.70
Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center. Am J Transplant (2011) 1.70
Sensitive PCR-restriction fragment length polymorphism assay for detection and genotyping of Giardia duodenalis in human feces. J Clin Microbiol (2002) 1.70
Sporadic cryptosporidiosis in children. Lancet (1983) 1.69
Detection of Legionella pneumophila using a real-time PCR hybridization assay. J Clin Microbiol (2000) 1.69
Unusual cryptosporidium species recovered from human faeces: first description of Cryptosporidium felis and Cryptosporidium 'dog type' from patients in England. J Med Microbiol (2001) 1.66
Grahamella in small woodland mammals in the U.K.: isolation, prevalence and host specificity. Ann Trop Med Parasitol (1994) 1.64
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Hypothesis: cryptosporidiosis in human beings is not primarily a zoonosis. J Infect (1984) 1.62
Genetic analysis of Cryptosporidium from 2414 humans with diarrhoea in England between 1985 and 2000. J Med Microbiol (2006) 1.62
The identification and characterisation of an unusual genotype of Cryptosporidium from human faeces as Cryptosporidium meleagridis. FEMS Microbiol Lett (2000) 1.57
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Molecular characterisation of Cryptosporidium parvum from two large suspected waterborne outbreaks. Outbreak Control Team South and West Devon 1995, Incident Management Team and Further Epidemiological and Microbiological Studies Subgroup North Thames 1997. Commun Dis Public Health (1998) 1.54
Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod (1994) 1.53
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
Characterization of allergens prepared from smooth and rough strains of Brucella melitensis. Br J Exp Pathol (1973) 1.52
A phage typing system for Listeria monocytogenes and its use in epidemiological studies. Clin Invest Med (1984) 1.51
Legionnaires' disease caused by Legionella pneumophila serogroup 3. Lancet (1979) 1.49
Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49
Phylogenetic diversity of intra-amoebal legionellae as revealed by 16S rRNA gene sequence comparison. Microbiology (1996) 1.49
Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol (1990) 1.49
Assessment of intercentre reproducibility and epidemiological concordance of Legionella pneumophila serogroup 1 genotyping by amplified fragment length polymorphism analysis. Eur J Clin Microbiol Infect Dis (2000) 1.48
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42
Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A (1980) 1.41
Genetic basis of tetracycline resistance in clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1992) 1.41
Serotyping of 80 strains from the WHO multicentre international typing study of Listeria monocytogenes. Int J Food Microbiol (1996) 1.40
Fulminant non--A-G viral hepatitis leading to liver transplantation. Arch Intern Med (2000) 1.39
Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocytosine, hydroxystilbamidine, and other substances. J Clin Pathol (1970) 1.39
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38
Phenotypic variation amongst genotypically homogeneous Legionella pneumophila serogroup 1 isolates: implications for the investigation of outbreaks of Legionnaires' disease. Epidemiol Infect (1990) 1.38
Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg (1989) 1.38
The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38
Peak flow measurement as a screening test for restrictive pulmonary disorders. Respir Med (1990) 1.38
Evaluation of sensitivity of two serological tests for diagnosing pneumonia caused by Legionella pneumophila serogroup 1. J Clin Pathol (1987) 1.36
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax (1984) 1.36
Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36
Formalised yolk sac antigen in early diagnosis of Legionnaires' disease caused by Legionella pneumophila serogroup 1. Lancet (1981) 1.32
Alleviation of drug withdrawal symptoms by treatment with a potent mixture of natural lipids. Eur J Pharmacol (1982) 1.31
Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J Clin Microbiol (2005) 1.29
Liver transplantation across ABO blood group barriers. Lancet (1990) 1.29
Listeriosis and food-borne transmission. Lancet (1988) 1.29
Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med (1998) 1.29
Further characterization of staphylococcal gamma-hemolysin. Infect Immun (1974) 1.27
Listeria ivanovii infection in a patient with AIDS. J Infect (1994) 1.27
Survey of Bartonella species infecting intradomicillary animals in the Huayllacallán Valley, Ancash, Peru, a region endemic for human bartonellosis. Am J Trop Med Hyg (1999) 1.27
Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology (2000) 1.24
Mycobacterial antigens in antibody responses of leprosy patients. Int J Lepr Other Mycobact Dis (1976) 1.23
Complementary and alternative medicine and psychologic factors: toward an individual differences model of complementary and alternative medicine use and outcomes. J Altern Complement Med (1999) 1.22
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol (2001) 1.22
Partial purification and properties of acyl-CoA synthetase of Escherichia coli. Eur J Biochem (1970) 1.21
Modification of a rapid method for the identification of gene-specific polymorphisms in Cryptosporidium parvum and its application to clinical and epidemiological investigations. Appl Environ Microbiol (2001) 1.21
Serological differentiation of Legionnaires' Disease and Mycoplasma pneumoniae pneumonia. Lancet (1980) 1.20
Cryptosporidium plus Campylobacter: an outbreak in a semi-rural population. J Hyg (Lond) (1986) 1.19